Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 1
2015 2
2016 1
2017 1
2020 1
2021 3
2023 1
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study.
European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration (EAS FHSC). European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration (EAS FHSC). Lancet Diabetes Endocrinol. 2024 Nov;12(11):811-823. doi: 10.1016/S2213-8587(24)00221-3. Epub 2024 Oct 4. Lancet Diabetes Endocrinol. 2024. PMID: 39374602 Free article.
Multizonal observational study conducted by clinical practitioners on evolocumab use in subjects with hyperlipidemia in Saudi Arabia and Kuwait: Results from the ZERBINI study.
Al Faraidy K, Akbar M, Shehri M, Aljarallah M, Abdin Hussein G, Dashti R, Al Qudaimi A, Al Nouri F, Awan Z, Essam A, Emara A. Al Faraidy K, et al. Among authors: al qudaimi a. PLoS One. 2023 Jan 20;18(1):e0278821. doi: 10.1371/journal.pone.0278821. eCollection 2023. PLoS One. 2023. PMID: 36662739 Free PMC article.
Familial Hypercholesterolemia in the Arabian Gulf Region: Clinical results of the Gulf FH Registry.
Alhabib KF, Al-Rasadi K, Almigbal TH, Batais MA, Al-Zakwani I, Al-Allaf FA, Al-Waili K, Zadjali F, Alghamdi M, Alnouri F, Awan Z, Kinsara AJ, AlQudaimi A, Almahmeed W, Sabbour H, Traina M, Atallah B, Al-Jarallah M, AlSarraf A, AlSayed N, Amin H, Altaradi H. Alhabib KF, et al. PLoS One. 2021 Jun 4;16(6):e0251560. doi: 10.1371/journal.pone.0251560. eCollection 2021. PLoS One. 2021. PMID: 34086694 Free PMC article.
Assessment of stroke risk in Middle Eastern patients with atrial fibrillation: the Gulf SAFE registry.
Apostolakis S, Zubaid M, Rashed WA, Alsheikh-Ali AA, Almahmeed W, Shehab A, Sulaiman K, Alqudaimi A, Asaad N, Amin H, Lane DA, Lip GY; Gulf Survey of Atrial Fibrillation Events Investigators. Apostolakis S, et al. Int J Cardiol. 2013 Sep 30;168(2):1644-6. doi: 10.1016/j.ijcard.2013.02.003. Epub 2013 Mar 5. Int J Cardiol. 2013. PMID: 23481910 No abstract available.
Sex differences in management and outcomes of patients with atrial fibrillation in the Middle East: Gulf survey of atrial fibrillation events (Gulf SAFE).
Shehab A, Zubaid M, Bhagavathula AS, Rashed WA, Alsheikh-Ali AA, AlMahmeed W, Sulaiman K, Al-Zakwani I, AlQudaimi A, Asaad N, Amin H; Gulf Survey of Atrial Fibrillation Events (Gulf SAFE) investigators. Shehab A, et al. PLoS One. 2017 May 17;12(5):e0175405. doi: 10.1371/journal.pone.0175405. eCollection 2017. PLoS One. 2017. PMID: 28520719 Free PMC article.
Impact of Digoxin on Mortality in Patients With Atrial Fibrillation Stratified by Heart Failure: Findings From Gulf Survey of Atrial Fibrillation Events in the Middle East.
Al-Zakwani I, Panduranga P, Zubaid M, Sulaiman K, Rashed WA, Alsheikh-Ali AA, AlMahmeed W, Shehab A, Al Qudaimi A, Asaad N, Amin H. Al-Zakwani I, et al. Among authors: al qudaimi a. J Cardiovasc Pharmacol Ther. 2016 May;21(3):273-9. doi: 10.1177/1074248415603505. Epub 2015 Sep 3. J Cardiovasc Pharmacol Ther. 2016. PMID: 26341119